WO1996007637A1 - Novel phenylalkylaminoalcohol carbamates and process for preparing the same - Google Patents

Novel phenylalkylaminoalcohol carbamates and process for preparing the same Download PDF

Info

Publication number
WO1996007637A1
WO1996007637A1 PCT/KR1995/000114 KR9500114W WO9607637A1 WO 1996007637 A1 WO1996007637 A1 WO 1996007637A1 KR 9500114 W KR9500114 W KR 9500114W WO 9607637 A1 WO9607637 A1 WO 9607637A1
Authority
WO
WIPO (PCT)
Prior art keywords
structural formula
phenylalaninol
represented
carbamoyl
following structural
Prior art date
Application number
PCT/KR1995/000114
Other languages
English (en)
French (fr)
Inventor
Yong Moon Choi
Jai Kook Byun
Original Assignee
Yukong Limited
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority to KR1994/22798 priority Critical
Priority to KR1019940022798A priority patent/KR100197892B1/ko
Application filed by Yukong Limited filed Critical Yukong Limited
Publication of WO1996007637A1 publication Critical patent/WO1996007637A1/en

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07CACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C271/00Derivatives of carbamic acids, i.e. compounds containing any of the groups, the nitrogen atom not being part of nitro or nitroso groups
    • C07C271/06Esters of carbamic acids
    • C07C271/08Esters of carbamic acids having oxygen atoms of carbamate groups bound to acyclic carbon atoms
    • C07C271/10Esters of carbamic acids having oxygen atoms of carbamate groups bound to acyclic carbon atoms with the nitrogen atoms of the carbamate groups bound to hydrogen atoms or to acyclic carbon atoms
    • C07C271/12Esters of carbamic acids having oxygen atoms of carbamate groups bound to acyclic carbon atoms with the nitrogen atoms of the carbamate groups bound to hydrogen atoms or to acyclic carbon atoms to hydrogen atoms or to carbon atoms of unsubstituted hydrocarbon radicals
    • YGENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02PCLIMATE CHANGE MITIGATION TECHNOLOGIES IN THE PRODUCTION OR PROCESSING OF GOODS
    • Y02P20/00Technologies relating to chemical industry
    • Y02P20/50Improvements relating to the production of products other than chlorine, adipic acid, caprolactam, or chlorodifluoromethane, e.g. bulk or fine chemicals or pharmaceuticals
    • Y02P20/55Synthetic design, e.g. reducing the use of auxiliary or protecting groups
PCT/KR1995/000114 1994-09-09 1995-09-06 Novel phenylalkylaminoalcohol carbamates and process for preparing the same WO1996007637A1 (en)

Priority Applications (2)

Application Number Priority Date Filing Date Title
KR1994/22798 1994-09-09
KR1019940022798A KR100197892B1 (ko) 1994-09-09 1994-09-09 신규한 페닐알킬아미노 카바메이트 화합물과 그의 제조방법

Applications Claiming Priority (6)

Application Number Priority Date Filing Date Title
US08/619,657 US5955499A (en) 1994-09-09 1995-09-06 Phenylalkylaminoalcohol carbamates and process for preparing the same
DE69513140A DE69513140D1 (de) 1994-09-09 1995-09-06 Neue phenylalkylaminoalkohol-carbamate und ein verfahren zu ihrer herstellung
EP95931444A EP0728129B1 (en) 1994-09-09 1995-09-06 Novel phenylalkylaminoalcohol carbamates and process for preparing the same
AU34856/95A AU700544B2 (en) 1994-09-09 1995-09-06 Novel phenylalkylaminoalcohol carbamates and process for preparing the same
RU96113126/04A RU2104266C1 (ru) 1994-09-09 1995-09-06 Карбаматы фенилалкиламиноспиртов и способы их получения
DE69513140T DE69513140T2 (de) 1994-09-09 1995-09-06 Neue phenylalkylaminoalkohol-carbamate und ein verfahren zu ihrer herstellung

Publications (1)

Publication Number Publication Date
WO1996007637A1 true WO1996007637A1 (en) 1996-03-14

Family

ID=19392447

Family Applications (1)

Application Number Title Priority Date Filing Date
PCT/KR1995/000114 WO1996007637A1 (en) 1994-09-09 1995-09-06 Novel phenylalkylaminoalcohol carbamates and process for preparing the same

Country Status (11)

Country Link
US (1) US5955499A (e)
EP (1) EP0728129B1 (e)
JP (1) JP2680478B2 (e)
KR (1) KR100197892B1 (e)
CN (1) CN1069635C (e)
AU (1) AU700544B2 (e)
CA (1) CA2176012C (e)
DE (2) DE69513140D1 (e)
ES (1) ES2140703T3 (e)
RU (1) RU2104266C1 (e)
WO (1) WO1996007637A1 (e)

Cited By (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0815074B1 (en) * 1995-02-11 2001-10-04 SK Corporation O-carbamoyl-(d)-phenylalanilol compounds and process for preparing the same
WO2006050037A1 (en) * 2004-10-28 2006-05-11 Sk Corporation Adjunctive therapy for depression
WO2008048801A2 (en) * 2006-10-13 2008-04-24 Janssen Pharmaceutica Nv Phenylalkylamino carbamate compositions
WO2012002688A3 (en) * 2010-06-30 2012-04-26 Sk Biopharmaceuticals Co., Ltd. Methods of treating restless legs syndrome
WO2012002687A3 (en) * 2010-06-30 2012-04-26 Sk Biopharmaceuticals Co., Ltd. Methods for treating bipolar disorder
US8440715B2 (en) 2005-06-08 2013-05-14 Sk Biopharmaceuticals Co., Ltd. Treatment of sleep-wake disorders
US8895609B2 (en) 2009-11-06 2014-11-25 Sk Biopharmaceuticals Co., Ltd. Methods for treating attention-deficit/hyperactivity disorder
US8927602B2 (en) 2009-11-06 2015-01-06 Sk Biopharmaceuticals Co., Ltd. Methods for treating fibromyalgia syndrome
US9226910B2 (en) 2013-07-18 2016-01-05 Jazz Pharmaceuticals International Iii Limited Treatment for obesity
US9359290B2 (en) 2013-03-13 2016-06-07 Jazz Pharmaceuticals International Iii Limited Treatment of cataplexy
US9464041B2 (en) 2009-06-22 2016-10-11 Sk Biopharmaceuticals Co., Ltd. Methods for treating or preventing fatigue

Families Citing this family (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20030069630A1 (en) * 2001-03-02 2003-04-10 Robert Burgermeister Stent with radiopaque markers incorporated thereon
AT459393T (de) * 2005-06-22 2010-03-15 Sk Holdings Co Ltd Behandlung der sexuellen dysfunktion
US8642772B2 (en) 2008-10-14 2014-02-04 Sk Biopharmaceuticals Co., Ltd. Piperidine compounds, pharmaceutical composition comprising the same and its use
US8232315B2 (en) * 2009-06-26 2012-07-31 Sk Biopharmaceuticals Co., Ltd. Methods for treating drug addiction and improving addiction-related behavior
TW201623224A (en) 2014-02-28 2016-07-01 Sk Biopharmaceuticals Co Ltd Aminocarbonylcarbamate compounds
US10195151B2 (en) 2016-09-06 2019-02-05 Jazz Pharmaceuticals International Iii Limited Formulations of (R)-2-amino-3-phenylpropyl carbamate
WO2018067971A1 (en) 2016-10-06 2018-04-12 Jazz Pharmaceuticals International Iii Limited Carbamoyl phenylalaninol compounds and uses therof
WO2018133703A1 (zh) * 2017-01-20 2018-07-26 苏州科睿思制药有限公司 R228060 盐酸盐的晶型及其制备方法和用途

Citations (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB1434826A (en) * 1973-11-14 1976-05-05 Gallardo Antonio Sa Esters and carbamates of aminoalkanols

Patent Citations (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB1434826A (en) * 1973-11-14 1976-05-05 Gallardo Antonio Sa Esters and carbamates of aminoalkanols

Cited By (29)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0815074B1 (en) * 1995-02-11 2001-10-04 SK Corporation O-carbamoyl-(d)-phenylalanilol compounds and process for preparing the same
US8729120B2 (en) 2004-10-28 2014-05-20 Sk Biopharmaceuticals Co., Ltd. Adjunctive therapy for depression
WO2006050037A1 (en) * 2004-10-28 2006-05-11 Sk Corporation Adjunctive therapy for depression
US9604917B2 (en) 2005-06-08 2017-03-28 Sk Biopharmaceuticals Co., Ltd. Treatment of sleep-wake disorders
US8877806B2 (en) 2005-06-08 2014-11-04 Sk Biopharmaceuticals Co., Ltd. Treatment of sleep-wake disorders
US8440715B2 (en) 2005-06-08 2013-05-14 Sk Biopharmaceuticals Co., Ltd. Treatment of sleep-wake disorders
WO2008048801A2 (en) * 2006-10-13 2008-04-24 Janssen Pharmaceutica Nv Phenylalkylamino carbamate compositions
WO2008048801A3 (en) * 2006-10-13 2008-06-05 Janssen Pharmaceutica Nv Phenylalkylamino carbamate compositions
US9464041B2 (en) 2009-06-22 2016-10-11 Sk Biopharmaceuticals Co., Ltd. Methods for treating or preventing fatigue
US9999609B2 (en) 2009-06-22 2018-06-19 Sk Biopharmaceuticals Co., Ltd. Methods for treating or preventing fatigue
US9688620B2 (en) 2009-11-06 2017-06-27 Sk Biopharmaceuticals Co., Ltd. Methods for treating fibromyalgia syndrome
US8895609B2 (en) 2009-11-06 2014-11-25 Sk Biopharmaceuticals Co., Ltd. Methods for treating attention-deficit/hyperactivity disorder
US8927602B2 (en) 2009-11-06 2015-01-06 Sk Biopharmaceuticals Co., Ltd. Methods for treating fibromyalgia syndrome
US9663455B2 (en) 2009-11-06 2017-05-30 Sk Biopharmaceuticals Co., Ltd. Methods for treating attention-deficit/hyperactivity disorder
US10202335B2 (en) 2009-11-06 2019-02-12 Sk Biopharmaceuticals Co., Ltd. Methods for treating attention-deficit/hyperactivity disorder
US9907777B2 (en) 2010-06-30 2018-03-06 Sk Biopharmaceuticals Co., Ltd. Methods for treating bipolar disorder
AU2011272156B2 (en) * 2010-06-30 2015-02-12 Sk Biopharmaceuticals Co., Ltd. Methods for treating bipolar disorder
KR101828934B1 (ko) 2010-06-30 2018-03-29 에스케이바이오팜 주식회사 양극성 장애의 치료방법
EP2590645A4 (en) * 2010-06-30 2014-01-22 Sk Biopharmaceuticals Co Ltd Methods for treating bipolar disorder
US9610274B2 (en) 2010-06-30 2017-04-04 Sk Biopharmaceuticals Co., Ltd. Methods for treating bipolar disorder
WO2012002688A3 (en) * 2010-06-30 2012-04-26 Sk Biopharmaceuticals Co., Ltd. Methods of treating restless legs syndrome
EP2588099B1 (en) * 2010-06-30 2017-05-24 SK Biopharmaceuticals Co., Ltd. Carbamates for use in treating restless legs syndrome
EP2590645A2 (en) * 2010-06-30 2013-05-15 SK Biopharmaceuticals Co., Ltd. Methods for treating bipolar disorder
WO2012002687A3 (en) * 2010-06-30 2012-04-26 Sk Biopharmaceuticals Co., Ltd. Methods for treating bipolar disorder
US9359290B2 (en) 2013-03-13 2016-06-07 Jazz Pharmaceuticals International Iii Limited Treatment of cataplexy
US9585863B2 (en) 2013-03-13 2017-03-07 Jazz Pharmaceuticals International Iii Limited Treatment of cataplexy
US9649291B2 (en) 2013-07-18 2017-05-16 Jazz Pharmaceuticals International Iii Limited Treatment for obesity
US10105341B2 (en) 2013-07-18 2018-10-23 Jazz Pharmaceuticals International Iii Limited Treatment for obesity
US9226910B2 (en) 2013-07-18 2016-01-05 Jazz Pharmaceuticals International Iii Limited Treatment for obesity

Also Published As

Publication number Publication date
CN1135209A (zh) 1996-11-06
US5955499A (en) 1999-09-21
DE69513140T2 (de) 2000-08-17
EP0728129B1 (en) 1999-11-03
AU700544B2 (en) 1999-01-07
JPH09503231A (ja) 1997-03-31
AU3485695A (en) 1996-03-27
CN1069635C (zh) 2001-08-15
JP2680478B2 (ja) 1997-11-19
KR100197892B1 (ko) 1999-06-15
RU2104266C1 (ru) 1998-02-10
ES2140703T3 (es) 2000-03-01
DE69513140D1 (de) 1999-12-09
EP0728129A1 (en) 1996-08-28
CA2176012A1 (en) 1996-03-14
CA2176012C (en) 1999-01-05

Similar Documents

Publication Publication Date Title
KR920003819B1 (ko) (s)-알파-에틸-2-옥소-1-피롤리딘아세트아미드의 제조 방법
AU625511B2 (en) 3-aminopiperidine derivatives and related nitrogen containing heterocycles
US5604223A (en) N acyl 2 3 benzodiazepine derivatives pharmaceutical compositions containing them and process for preparing same
JP2656702B2 (ja) ペプチド性キヌクリジン
US6127412A (en) Halogen substituted carbamate compounds from 2-phenyl-1,2-ethanediol
JP5046465B2 (ja) アリールアルキルアミンから誘導されるカルバメート
USRE33024E (en) Bronchodilating 8-hydroxy-5-(1R)-1-hydroxy-2-(N-((1R)-2-(p-methoxyphenyl)-1-methylethyl)-amino)ethyl) carbostyril and intermediates thereof
US6534514B1 (en) Kappa opioid receptor antagonists
CA1111850A (en) Phthalazine derivatives having phosphodiesterase inhibitory and cardiac stimulating properties
RU2351588C2 (ru) Производные n-фенил(пиперидин-2-ил)метил-бензамида и их применение в терапии
EP1682503B1 (fr) Derives de n-[phenyl(alkylpiperidin-2-yl)methyl]benzamide, leur preparation et leur application en therapeutique
EP0815080B1 (en) Di-substituted 1,4-piperidine esters and amides having 5-ht4 antagonistic activity
AU679207B2 (en) Azacyclic compounds, compositions containing them and their use as tachykinin antagonists
EP0170213B1 (en) Glutarimide antianxiety and antihypertensive agents
EP0363415B1 (en) Compounds for the treatment of alzheimer's disease
EP0707006B1 (de) Aroyl-piperidin-Derivate
RU2386614C2 (ru) Производные n-[фенил(пирролидин-2-ил)метил]бензамида и n-[(азепан-2-ил)фенилметил]бензамида, способ их получения и их применение в терапии
US20030064980A1 (en) Selective neurokinin antagonists
EP0830863B1 (de) Die gastrointestinale Durchblutung fördernde Arzneimittel
EP1499589B1 (fr) Derives de n-¬phenyl(piperidin-2-yl)methyl|benzamide, leur preparation et leur application en therapeutique
KR910000234B1 (ko) 시스, 엔도-2-아자비사이클로[5.3.0]데칸-3-카복실산 유도체의 제조방법
SU1297727A3 (ru) Способ получени @ -циклоалкилалканоил пиперазинов или их физиологически совместимых солей с кислотами
EP0100200B1 (en) 2-substituted 4-amino-6,7-dimethoxyquinolines
RU2084453C1 (ru) Способ получения ароматических производных или их солей с органическими или неорганическими кислотами или их рацематов
KR910007882B1 (ko) 1-벤질-아미노알킬-피롤리디논의 제조방법

Legal Events

Date Code Title Description
WWE Wipo information: entry into national phase

Ref document number: 95190875.8

Country of ref document: CN

AK Designated states

Kind code of ref document: A1

Designated state(s): AU CA CN JP RU US

AL Designated countries for regional patents

Kind code of ref document: A1

Designated state(s): AT BE CH DE DK ES FR GB GR IE IT LU MC NL PT SE

WWE Wipo information: entry into national phase

Ref document number: 2176012

Country of ref document: CA

WWE Wipo information: entry into national phase

Ref document number: 1995931444

Country of ref document: EP

121 Ep: the epo has been informed by wipo that ep was designated in this application
WWE Wipo information: entry into national phase

Ref document number: 08619657

Country of ref document: US

WWP Wipo information: published in national office

Ref document number: 1995931444

Country of ref document: EP

WWG Wipo information: grant in national office

Ref document number: 1995931444

Country of ref document: EP